- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Trastuzumab deruxtecan
Total 1199 results
-
Shi YanxiaRecruitingBreast Cancer | Effects of Chemotherapy | Breast Cancer ModelChina
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
Yizhuo ZhangRecruitingPediatric Solid Tumor, Unspecified, Protocol SpecificChina
-
Tianjin Medical University General HospitalRecruitingPostoperative Pain | Postoperative Cognitive Dysfunction | Total Knee ArthroplastyChina
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerSpain, China, United States, Italy, United Kingdom, Korea, Republic of, Belgium, France, Germany, Poland, Japan, Vietnam, Canada, Brazil, India, Malaysia, Taiwan, Thailand, Australia, Austria, Turkey, Hong Kong, Bulgaria, Switzerland, H... and more
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Celularity IncorporatedActive, not recruitingMetastatic HER2 Positive Gastroesophageal Junction CancerUnited States
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.; Cancer International Research Group (CIRG)TerminatedBreast CancerKorea, Republic of, United States, Canada, Spain, Ireland, Australia, Argentina, China, United Kingdom, Germany, Brazil, Hong Kong, France, Israel, Taiwan, Serbia, Belgium, Thailand, Croatia, Egypt, Italy, Philippines, Bosnia and Herzegovina and more
-
Western Regional Medical CenterTerminated
-
Örebro University, SwedenCompletedPostoperative Pain Intensity | Rescue Pain RequirementsSweden
-
SanofiCompleted
-
Samsung Medical CenterMinistry of Health, Republic of KoreaRecruitingRelapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
Hoffmann-La RocheGenentech, Inc.; Breast International GroupActive, not recruitingBreast CancerUnited States, Belgium, Canada, Australia, Austria, Bulgaria, China, Croatia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Panama, Slovenia, Spain, Taiwan, United Kingdom, Colombia, Czechia, El Salvador and more
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
Washington University School of MedicinePfizer; Rising Tide FoundationTerminatedBreast Cancer | Breast Carcinoma | Cancer of BreastUnited States
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
Fate TherapeuticsTerminatedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | GastroEsophageal CancerUnited States
-
Washington University School of MedicineCompletedStomach Neoplasms | Esophageal NeoplasmsUnited States
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Vanderbilt University Medical CenterVeloxis PharmaceuticalsEnrolling by invitationLung Transplant; ComplicationsUnited States
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
German Breast GroupCelgene Corporation; AmgenCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
University of California, San FranciscoPuma Biotechnology, Inc.CompletedHER2-positive Breast Cancer | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States
-
Hoffmann-La RocheCompletedColorectal CancerItaly, Korea, Republic of, United Kingdom, Belgium, Argentina, Denmark, Greece, Netherlands, Slovenia, Spain, Sweden, Turkey, Brazil, Bosnia and Herzegovina, France, Germany, Portugal, Egypt, Poland, Slovakia, Mexico, Serbia, Russian...
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Eli Lilly and CompanyActive, not recruitingBreast NeoplasmsUnited States
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
AstraZenecaDaiichi SankyoRecruitingGastric Cancer | Colorectal Cancer | Ovarian Cancer | Endometrial Cancer | Urothelial Cancer | Biliary Tract Cancer | Metastatic Castration-resistant Prostate CancerSpain, China, Korea, Republic of, Canada, Italy, Poland, Turkey, United Kingdom, Japan, Taiwan, United States, France, Germany, Switzerland
-
Oslo University HospitalRecruitingMetastatic Colorectal CancerNorway
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
Washington University School of MedicineGenentech, Inc.Terminated
-
George Albert FisherSanofi; GlaxoSmithKlineCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
Gruppo Oncologico del Nord-OvestSeagen Inc.; Servier; Foundation MedicineRecruitingStage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon CancerItaly
-
Prof. Wolfgang JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHActive, not recruiting
-
University of California, IrvineCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownBreast Cancer Nos PremenopausalChina
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
Shandong Cancer Hospital and InstituteUnknown
-
Palleos Healthcare GmbHRoche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUPCompleted
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
Columbia UniversityCompletedBreast Cancer | Locally Advanced Malignant NeoplasmUnited States
-
OHSU Knight Cancer InstituteTerminated
-
European Organisation for Research and Treatment...UnknownLymphoma | LeukemiaFrance, Belgium, Portugal
-
Xijing HospitalUnknown